Viewing Study NCT04148105


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-01-08 @ 7:56 PM
Study NCT ID: NCT04148105
Status: TERMINATED
Last Update Posted: 2024-05-31
First Post: 2019-10-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)
Sponsor: Henry Ford Health System
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 1072359
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators